Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMXH65Z)

Drug Name
Piperazine carbamic compound 5 Drug Info
Synonyms PMID29053063-Compound-9b
Cross-matching ID
TTD Drug ID
DMXH65Z

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Patented Agent(s)
Download the Complete Related Drug List
Drug(s) Targeting Monoglyceride lipase (MAGL)
Drug Name Drug ID Indication ICD 11 Highest Status REF
ABX-1431 DM9SYVJ Neuropathic pain 8E43.0 Phase 1 [2]
PMID29053063-Compound-11d DMDRK68 N. A. N. A. Patented [1]
Piperazine carbamic compound 1 DMZSYU4 N. A. N. A. Patented [1]
Piperazine carbamic compound 2 DMMQ0ZO N. A. N. A. Patented [1]
Pyrazole derivative 82 DMETCI3 N. A. N. A. Patented [1]
Pyrazole derivative 81 DMWT437 N. A. N. A. Patented [1]
PMID29053063-Compound-15 DM07U5R N. A. N. A. Patented [1]
Pyrazole derivative 80 DMQ3TGM N. A. N. A. Patented [1]
Carbamide derivative 24 DMD6Y73 N. A. N. A. Patented [1]
Piperazine carbamic compound 4 DMKZUO4 N. A. N. A. Patented [1]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Targeting Monoacylglycerol lipase ABHD6 (ABHD6)
Drug Name Drug ID Indication ICD 11 Highest Status REF
PMID29053063-Compound-11d DMDRK68 N. A. N. A. Patented [1]
Piperazine carbamic compound 1 DMZSYU4 N. A. N. A. Patented [1]
Piperazine carbamic compound 2 DMMQ0ZO N. A. N. A. Patented [1]
Pyrazole derivative 82 DMETCI3 N. A. N. A. Patented [1]
Pyrazole derivative 81 DMWT437 N. A. N. A. Patented [1]
Pyrazole derivative 80 DMQ3TGM N. A. N. A. Patented [1]
Piperazine carbamic compound 4 DMKZUO4 N. A. N. A. Patented [1]
PMID29053063-Compound-11c DMLMHR5 N. A. N. A. Patented [1]
⏷ Show the Full List of 8 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Monoacylglycerol lipase ABHD6 (ABHD6) TTSINOV ABHD6_HUMAN Inhibitor [1]
Monoglyceride lipase (MAGL) TTZ963I MGLL_HUMAN Inhibitor [1]

References

1 A patent review of Monoacylglycerol Lipase (MAGL) inhibitors (2013-2017).Expert Opin Ther Pat. 2017 Dec;27(12):1341-1351.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)